[go: up one dir, main page]

CR20160307A - Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas - Google Patents

Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas

Info

Publication number
CR20160307A
CR20160307A CR20160307A CR20160307A CR20160307A CR 20160307 A CR20160307 A CR 20160307A CR 20160307 A CR20160307 A CR 20160307A CR 20160307 A CR20160307 A CR 20160307A CR 20160307 A CR20160307 A CR 20160307A
Authority
CR
Costa Rica
Prior art keywords
compositions
making
methods
same
sample
Prior art date
Application number
CR20160307A
Other languages
English (en)
Inventor
Vincent C Giampapa
Original Assignee
Advanced Regen Medical Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Regen Medical Tech Llc filed Critical Advanced Regen Medical Tech Llc
Publication of CR20160307A publication Critical patent/CR20160307A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un método que comprende obtener una primera muestra de células de un primer individuo; obtener una segunda muestra de células de un segundo individuo; cultivar la primera muestra de células en presencia de al menos una porción de un medio de cultivo de la segunda muestra de células por un periodo con un rango entre aproximadamente 24 horas y aproximadamente 6 semanas para producir una composición restauradora; y poner en contacto la composición restauradora con la segunda muestra de células por un periodo con un rango entre aproximadamente 24 horas y aproximadamente 6 semanas para producir una composición restaurada.
CR20160307A 2013-12-20 2014-12-19 Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas CR20160307A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361919165P 2013-12-20 2013-12-20
PCT/US2014/071667 WO2015095794A1 (en) 2013-12-20 2014-12-19 Compositions for cellular restoration and methods of making and using same

Publications (1)

Publication Number Publication Date
CR20160307A true CR20160307A (es) 2016-11-08

Family

ID=53398909

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160307A CR20160307A (es) 2013-12-20 2014-12-19 Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas

Country Status (5)

Country Link
US (2) US20150174166A1 (es)
EP (1) EP3083939A4 (es)
JP (1) JP6353073B2 (es)
CR (1) CR20160307A (es)
WO (1) WO2015095794A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
EP3689357B1 (en) 2013-04-09 2024-12-04 Advanced Regen Medical Technologies, LLC Compositions for cellular restoration and methods of making and using same
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
WO2015095794A1 (en) 2013-12-20 2015-06-25 Advanced ReGen Medical Technologies, LLC Compositions for cellular restoration and methods of making and using same
WO2017189842A1 (en) * 2016-04-27 2017-11-02 The Scripps Research Institute Extracellular vesicles from young stem cells or serum for age-related therapies
JP6999575B2 (ja) 2016-04-29 2022-01-18 アドヴァンスド リジェン メディカル テクノロジーズ，エルエルシー マイクロｒｎａ組成物並びにその作製及び使用方法
US11497708B2 (en) 2016-06-16 2022-11-15 BEMY Cosmetics, Inc. Customized cosmetic compositions, and methods of rejuvenating and utilizing conditioned media and/or components thereof
US10806942B2 (en) 2016-11-10 2020-10-20 Qoravita LLC System and method for applying a low frequency magnetic field to biological tissues
CA3085471A1 (en) 2017-12-28 2019-07-04 Codiak Biosciences, Inc. Exosomes for immuno-oncology and anti-inflammatory therapy
EP3740576A4 (en) 2018-01-18 2021-10-20 Advanced Regen Medical Technologies, LLC THERAPEUTIC COMPOSITIONS AND THEIR PREPARATION AND USE METHODS
US20220073901A1 (en) * 2018-10-02 2022-03-10 Stemon Inc. Composition for extending telomere of cell and preparation method therefor

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2984164A (en) 1955-01-12 1961-05-16 Voigtlaender Ag Automatic exposure adjustment in photographic cameras
US3122333A (en) 1961-02-23 1964-02-25 Gen Mills Inc Tape quantity sensing and winding control apparatus
US3083939A (en) 1961-03-02 1963-04-02 Jr Edward J Gallagher Floating shockproof and vibrationless assembly for delicate instrument panel mount
US3436081A (en) 1967-06-26 1969-04-01 Sandor A Ungar Game equipment
US6319471B1 (en) 1992-07-10 2001-11-20 Gambro, Inc. Apparatus for producing blood component products
US20040199935A1 (en) 1999-06-30 2004-10-07 Chapman Karen B. Cytoplasmic transfer to de-differentiate recipient cells
EP1946783B1 (en) 2000-03-09 2011-09-07 CaridianBCT, Inc. Extracorporeal blood processing apparatus
AU2002952944A0 (en) 2002-11-27 2002-12-12 Human Genetic Signatures Pty Ltd Restoration of methylation states in cells
US20080213812A1 (en) 2003-09-29 2008-09-04 Andrews William H Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
US20050158285A1 (en) 2003-12-09 2005-07-21 Giampapa Vincent C. Method of re-profiling adult stem cells using embryonic stem cell electromagnetic signals
EP1766053A4 (en) 2004-06-02 2007-12-12 Sourcepharm Inc MICROVESICLES CONTAINING RNA AND METHODS
AU2005262319A1 (en) 2004-07-01 2006-01-19 Orthogen Ag Immunosuppressive exosomes
US20070196918A1 (en) 2004-07-15 2007-08-23 Sayre Chauncey B Reprogramming of adult human testicular stem cells to pluripotent germ-line stem cells
JP5202953B2 (ja) 2004-11-08 2013-06-05 ザ ジョンズ ホプキンス ユニバーシティー 心臓幹細胞
CN101535331B (zh) 2005-04-29 2013-01-30 洛克菲勒大学 人类微小rna以及用于抑制人类微小rna的方法
US20070025973A1 (en) 2005-07-29 2007-02-01 Fitzsimmons Frederick J Reprogramming of adult or neonic stem cells and methods of use
BRPI0617664B8 (pt) 2005-10-21 2021-05-25 Chugai Pharmaceutical Co Ltd uso de um anticorpo que reconhece a il-6 para a produção de uma composição farmacêutica para tratar o enfarte do miocárdio ou suprimir a remodelagem ventricular esquerda depois do enfarte do miocárdio
WO2007133812A2 (en) 2005-12-30 2007-11-22 Philadelphia Health & Education Corporation, D/B/A Drexel University College Of Medicine Improved carriers for delivery of nucleic acid agents to cells and tissues
EP1810686A1 (en) 2006-01-19 2007-07-25 Academisch Ziekenhuis Leiden Means and methods for modulating stem cell mobilization
GB0605450D0 (en) 2006-03-17 2006-04-26 Intercytex Ltd Cell co-culture
KR100832592B1 (ko) 2006-08-17 2008-05-27 박현숙 폴리머 막을 이용한 줄기세포와 피더세포의 공배양방법
CA2669304C (en) 2006-11-30 2016-10-25 Medipost Co., Ltd. Use of a composition contaning human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells
KR100959995B1 (ko) 2006-12-01 2010-05-28 메디포스트(주) 인간 제대혈 유래 간엽 줄기세포를 유효성분으로 포함하는,신경전구세포 또는 신경줄기세포의 신경세포로의 분화 및증식 유도용 조성물
CA2673793C (en) 2007-02-16 2016-01-26 The Johns Hopkins University Micrornas for diagnosis and treatment of cancer
US9205112B2 (en) 2007-04-23 2015-12-08 Creative Medical Health, Inc. Combination treatment of cardiovascular disease
KR101133387B1 (ko) 2007-07-16 2012-04-09 가톨릭대학교 산학협력단 중간엽기질세포를 이용한 성체줄기세포의 자가재생산을촉진하는 방법
WO2009079592A2 (en) 2007-12-17 2009-06-25 California Institute Of Technology Modulating immune system development and function through microrna mir-146
WO2009086425A1 (en) 2007-12-28 2009-07-09 Fate Therapeutics, Inc. Methods for reprogramming cells to a pluripotent state and therapeutic applications related thereto
PL2254586T3 (pl) 2008-02-22 2015-09-30 Agency For Science Tech And Research Astarstar Cząstki mezenchymalnych komórek macierzystych
EP2294196A1 (en) 2008-06-06 2011-03-16 Centre National de la Recherche Scientifique - CNRS Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna
EP2303292A4 (en) 2008-06-09 2013-01-02 New York Medical College COMPOSITIONS WITH CARDIAL STEM CELLS WITH OVEREXPRESSION OF SPECIFIC MICRORNAS AND METHOD FOR THEIR USE IN THE REPAIR OF THE CARED MYOCARDIC
WO2010150783A1 (ja) 2009-06-25 2010-12-29 株式会社 日立メディコ 医用画像撮影装置
US20120258093A1 (en) 2009-08-20 2012-10-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
US9078914B2 (en) 2009-09-10 2015-07-14 Velin-Pharma A/S Method for the preparation of micro-RNA and its therapeutic application
CN102686264A (zh) 2009-10-27 2012-09-19 雪松-西奈医疗中心 用于具有增强的细胞滞留的靶向细胞递送的外部磁力
EP2363136A1 (en) 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
US9249392B2 (en) 2010-04-30 2016-02-02 Cedars-Sinai Medical Center Methods and compositions for maintaining genomic stability in cultured stem cells
US8980279B2 (en) 2010-07-26 2015-03-17 Qu Biologics Personalized site-specific immunomodulation
JP2013537538A (ja) 2010-08-13 2013-10-03 ザ ユニバーシティ コート オブ ザ ユニバーシティ オブ グラスゴー 微小水泡および関連するマイクロｒｎａの治療用途
US20120093885A1 (en) * 2010-10-18 2012-04-19 Northwestern University Therapeutic vesicles
EP2629782B1 (en) 2010-10-18 2019-02-20 Agency For Science, Technology And Research Use of exosomes derived from mesenchymal stem cells to promote or enhance hair growth
SG190450A1 (en) 2010-12-20 2013-06-28 Agency Science Tech & Res Method of purifying exosomes
SG183579A1 (en) 2011-02-11 2012-09-27 Agency Science Tech & Res Methods of detecting therapeutic exosomes
US9241950B2 (en) 2011-04-28 2016-01-26 New York University MiR-33 inhibitors and uses thereof to decrease inflammation
WO2012159044A1 (en) 2011-05-18 2012-11-22 Wellstat Therapeutics Corporation Stem cell mobilization and tissue repair and regeneration
WO2012162741A1 (en) 2011-06-01 2012-12-06 Monash University Enrichment of cardiomyocytes
EP2535412A1 (en) 2011-06-17 2012-12-19 Universitat Pompeu-Fabra New treatment for muscular dystrophies
US8747915B1 (en) 2011-09-14 2014-06-10 Vincent C. Giampapa Dietary supplement system for multifunctional anti-aging management and method of use
WO2013048734A1 (en) 2011-09-28 2013-04-04 Tufts Medical Center, Inc. Treatment and prevention of cardiovascular disease with cell derived lipid vesicles, microvesicles and exosomes
WO2013066368A1 (en) 2011-10-03 2013-05-10 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Use of mirna 126 to produce hematopoietic stem cells
US9315776B2 (en) 2011-11-09 2016-04-19 National University Of Singapore Wharton's jelly mesenchymal stem cells and uses thereof
US9427450B2 (en) * 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
US20130236428A1 (en) 2012-03-08 2013-09-12 Vincent C. Giampapa Reprogramming of Aged Adult Stem Cells
US20150023935A1 (en) 2012-03-08 2015-01-22 Advanced ReGen Medical Technologies, Inc. Reprogramming of Aged Adult Stem Cells
GB201302468D0 (en) 2013-02-12 2013-03-27 Reneuron Ltd Stem cell product
WO2013170170A2 (en) 2012-05-10 2013-11-14 Board Of Regents Of The University Of Nebraska Compositions and methods for gene therapy
US9295696B2 (en) * 2012-06-08 2016-03-29 University of Pittsburgh—of the Commonwealth System of Higher Education Compositions and methods for restoring or rejuvenating stem/progenitor cell function
EP2687219A1 (en) 2012-07-18 2014-01-22 Universität Duisburg-Essen Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions
CN104703609B (zh) 2012-07-19 2019-02-19 兰诺龙有限公司 干细胞微粒
US9828603B2 (en) 2012-08-13 2017-11-28 Cedars Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration
CA2882966A1 (en) 2012-08-31 2014-03-06 Aptamir Therapeutics, Inc. Mirna modulators of chronic visceral inflammation
US9492484B2 (en) 2012-09-27 2016-11-15 The Regents Of The University Of California Cardiosphere derived cell population and methods of use
CZ2012678A3 (cs) 2012-10-04 2014-04-16 Primecell A.S. Způsob zpracování odběrů pupečníkové krve, zpracování a uchování získané odpadní pupečníkové krve a její terapeutické využití
US9242000B2 (en) 2012-10-18 2016-01-26 The Regents Of The University Of California Micro-RNAs and micro-RNA inhibitors to modulate blood vessel growth, patterning, tumor growth and malignant disease and method for making and using them
US20150273113A1 (en) 2012-10-26 2015-10-01 Cedars-Sinai Medical Center Therapeutic cells depleted of specific subpopulations of cells for use in tissue repair or regeneration
WO2014132327A1 (ja) 2013-02-26 2014-09-04 テルモ株式会社 血液成分分離装置
EP3689357B1 (en) 2013-04-09 2024-12-04 Advanced Regen Medical Technologies, LLC Compositions for cellular restoration and methods of making and using same
EP3033418B1 (en) 2013-08-14 2019-12-11 Reneuron Limited Stem cell microparticles and mirna
GB201317889D0 (en) 2013-10-09 2013-11-20 Reneuron Ltd Product and use
WO2015073625A2 (en) 2013-11-15 2015-05-21 The Mclean Hospital Corporation Synergistic genome-nonintegrating reprogramming by micrornas and transcription factors
AU2014360344B2 (en) 2013-12-04 2018-11-29 Board Of Regents, The University Of Texas System Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis
WO2015095794A1 (en) 2013-12-20 2015-06-25 Advanced ReGen Medical Technologies, LLC Compositions for cellular restoration and methods of making and using same
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
US20160346334A1 (en) 2014-02-05 2016-12-01 Stc.Unm Exosomes as a therapeutic for cancer
EP3122333A4 (en) 2014-03-24 2017-11-29 Advanced Regen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
US20150328263A1 (en) 2014-05-14 2015-11-19 University Of Maryland, Baltimore Cardiac stem cells for cardiac repair
ES2989898T3 (es) 2014-05-30 2024-11-28 Toray Industries Kit o dispositivo para la detección del cáncer de páncreas y método de detección
KR102725469B1 (ko) 2014-06-11 2024-11-04 국립연구개발법인 고쿠리츠간켄큐센터 담도암 검출 키트 또는 디바이스 및 검출 방법
RU2017100434A (ru) 2014-06-13 2018-07-18 Торэй Индастриз, Инк. Набор или устройство для обнаружения рака молочной железы и способ обнаружения
AU2015327812B2 (en) 2014-10-03 2021-04-15 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
EP3204117A4 (en) 2014-10-06 2018-05-09 Cedars-Sinai Medical Center Polarization of macrophages to a healing phenotype by cardiosphere-derived cells and by the exosomes secreted by such cells
US10624849B2 (en) 2015-09-28 2020-04-21 Northwestern University Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
US10982215B2 (en) 2015-12-09 2021-04-20 Alnylam Pharmaceuticals, Inc. Polynucleotide agents targeting programmed cell death 1 ligand 1 (PD-L1) and methods of use thereof
WO2017123662A1 (en) 2016-01-11 2017-07-20 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
JP6999575B2 (ja) 2016-04-29 2022-01-18 アドヴァンスド リジェン メディカル テクノロジーズ，エルエルシー マイクロｒｎａ組成物並びにその作製及び使用方法
EP3661526B1 (en) 2017-08-04 2023-07-12 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles for treatment and prevention of cancer
EP3740576A4 (en) 2018-01-18 2021-10-20 Advanced Regen Medical Technologies, LLC THERAPEUTIC COMPOSITIONS AND THEIR PREPARATION AND USE METHODS
AU2020241371A1 (en) 2019-03-18 2021-10-07 Advanced ReGen Medical Technologies, LLC Methods and clinical protocols and kits pertaining to making and using therapeutic compositions for cellular treatment

Also Published As

Publication number Publication date
JP2017503019A (ja) 2017-01-26
US11219643B2 (en) 2022-01-11
EP3083939A4 (en) 2017-05-17
US20180360878A1 (en) 2018-12-20
EP3083939A1 (en) 2016-10-26
WO2015095794A1 (en) 2015-06-25
JP6353073B2 (ja) 2018-07-04
US20150174166A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
CR20160307A (es) Composiciones para la restauración de células y métodos para la preparación y utilización de las mismas
MX2022003477A (es) Medio de cultivo celular complementado con taurina y metodos de uso.
AR090822A1 (es) Composiciones de cultivo de celulas y metodos para la produccion de polipeptidos
EP2373784A4 (en) GENERATION AND CONSERVATION OF STEM CELLS
CO6501191A2 (es) Medio de cultivo celular para expresión de la proteina adamts
EP2588594A4 (en) PROCESS FOR CULTIVATING UNDIFFERENCED CELLS USING DELAYED RELATED COMPOSITION COMPOSITIONS
EP3947642A4 (en) CULTURE MEDIUM FOR MAMMALIAN PLURIPOTENTE STEM CELLS, COMPOSITION AND METHODS
BR112013001089A2 (pt) composição de meio de cultura e método para cultivar células tronco mesenquimais derivadas de âmnio
AR094375A1 (es) Métodos de uso de inhibidores del ciclo celular para modular una o más propiedades de un cultivo celular
CO6561839A2 (es) Alteracion genómica dirigida
SG196784A1 (en) Stem cell cultures
CL2016003096A1 (es) Métodos para cosechar cultivos de células de mamífero
MX2016016076A (es) Composiciones de celulas t mejoradas.
EA201270300A1 (ru) Визуализация и оценка эмбрионов, яйцеклеток и стволовых клеток
EP2970890A4 (en) COMPOSITIONS AND METHOD FOR THE REPRODUCTION AND BREEDING OF EPITHELIC STEM CELLS
MY159971A (en) Multipotent/pluripotent cells and methods
MX2016016251A (es) Expansion de linfocitos con composicion de citocinas para inmunoterapia celular activa.
MY171710A (en) Culture medium composition, and method for culturing cell or tissue using said composition
BR112014000042A2 (pt) composição, meio de cultura celular, uso de uma composição, e, método para cultivar células
MX339624B (es) Composiciones mejoradas de celulas y metodos para preparar las mismas.
CR20120501A (es) Método y composición para la construcción de caminos y superficies
WO2016168890A8 (en) Generation of muscle-lineage cells from stem cells
GB201305388D0 (en) Benchmarks for normal cell identification
WO2012126013A3 (en) Method for making pluripotent stem cells
IN2014DN11272A (es)